Cargando…
Corrigendum: Doxycycline Inhibits Cancer Stem Cell-Like Properties via PAR1/FAK/PI3K/AKT Pathway in Pancreatic Cancer
Autores principales: | Liu, Huijuan, Tao, Honglian, Wang, Hongqi, Yang, Yuyan, Yang, Ru, Dai, Xintong, Ding, Xiujuan, Wu, Haidong, Chen, Shuang, Sun, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909380/ https://www.ncbi.nlm.nih.gov/pubmed/35280769 http://dx.doi.org/10.3389/fonc.2022.830506 |
Ejemplares similares
-
Doxycycline Inhibits Cancer Stem Cell-Like Properties via PAR1/FAK/PI3K/AKT Pathway in Pancreatic Cancer
por: Liu, Huijuan, et al.
Publicado: (2021) -
Doxycycline directly targets PAR1 to suppress tumor progression
por: Zhong, Weilong, et al.
Publicado: (2017) -
Doxycycline inhibits breast cancer EMT and metastasis through PAR-1/NF-κB/miR-17/E-cadherin pathway
por: Zhong, Weilong, et al.
Publicado: (2017) -
TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway
por: Song, Guohe, et al.
Publicado: (2016) -
Psychologic Stress Drives Progression of Malignant Tumors via DRD2/HIF1α Signaling
por: Liu, Huijuan, et al.
Publicado: (2021)